Dai-ichi Life Insurance Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.02M | Hold |
22,329
| – | – | 0.05% | 278 |
|
|
2026
Q1 | $1.79M | Sell |
22,329
-1,439
| -6% | -$119K | 0.05% | 269 |
|
|
2025
Q4 | $2.03M | Hold |
23,768
| – | – | 0.05% | 263 |
|
|
2025
Q3 | $1.85M | Hold |
23,768
| – | – | 0.05% | 281 |
|
|
2025
Q2 | $1.86M | Hold |
23,768
| – | – | 0.05% | 270 |
|
|
2025
Q1 | $1.72M | Sell |
23,768
-3,376
| -12% | -$242K | 0.05% | 282 |
|
|
2024
Q4 | $2.01M | Sell |
27,144
-18,000
| -40% | -$1.26M | 0.06% | 281 |
|
|
2024
Q3 | $2.98M | Sell |
45,144
-20,500
| -31% | -$1.49M | 0.08% | 222 |
|
|
2024
Q2 | $6.06M | Sell |
65,644
-6,920
| -10% | -$613K | 0.15% | 150 |
|
|
2024
Q1 | $6.93M | Buy |
72,564
+11,244
| +18% | +$945K | 0.16% | 128 |
|
|
2023
Q4 | $4.68M | Sell |
61,320
-65,703
| -52% | -$4.57M | 0.1% | 194 |
|
|
2023
Q3 | $8.8M | Sell |
127,023
-8,343
| -6% | -$670K | 0.19% | 111 |
|
|
2023
Q2 | $12.8M | Buy |
135,366
+25,353
| +23% | +$2.2M | 0.27% | 77 |
|
|
2023
Q1 | $9.1M | Buy |
110,013
+27,918
| +34% | +$2.19M | 0.2% | 97 |
|
|
2022
Q4 | $6.13M | Sell |
82,095
-7,856
| -9% | -$605K | 0.14% | 146 |
|
|
2022
Q3 | $7.43M | Sell |
89,951
-420
| -0.5% | -$40.4K | 0.18% | 109 |
|
|
2022
Q2 | $8.59M | Sell |
90,371
-10,559
| -10% | -$1.09M | 0.19% | 104 |
|
|
2022
Q1 | $11.9M | Sell |
100,930
-765
| -0.8% | -$85.8K | 0.19% | 113 |
|
|
2021
Q4 | $13.2M | Sell |
101,695
-771
| -0.8% | -$89.9K | 0.17% | 113 |
|
|
2021
Q3 | $11.6M | Sell |
102,466
-13,952
| -12% | -$1.59M | 0.15% | 123 |
|
|
2021
Q2 | $12.1M | Sell |
116,418
-193
| -0.2% | -$18.2K | 0.15% | 125 |
|
|
2021
Q1 | $9.75M | Sell |
116,611
-1,416
| -1% | -$120K | 0.13% | 125 |
|
|
2020
Q4 | $10.8M | Buy |
118,027
+36,832
| +45% | +$3.06M | 0.16% | 112 |
|
|
2020
Q3 | $6.48M | Sell |
81,195
-1,249
| -2% | -$97.5K | 0.12% | 140 |
|
|
2020
Q2 | $5.7M | Sell |
82,444
-2,015
| -2% | -$143K | 0.13% | 134 |
|
|
2020
Q1 | $5.31M | Buy |
84,459
+23,286
| +38% | +$1.68M | 0.2% | 117 |
|
|
2019
Q4 | $4.76M | Sell |
61,173
-44,880
| -42% | -$3.5M | 0.11% | 195 |
|
|
2019
Q3 | $7.77M | Sell |
106,053
-24,225
| -19% | -$1.7M | 0.19% | 129 |
|
|
2019
Q2 | $8.02M | Buy |
130,278
+34,890
| +37% | +$2.11M | 0.19% | 121 |
|
|
2019
Q1 | $6.08M | Sell |
95,388
-83,658
| -47% | -$4.77M | 0.15% | 152 |
|
|
2018
Q4 | $9.14M | Buy |
179,046
+40,848
| +30% | +$2.07M | 0.25% | 105 |
|
|
2018
Q3 | $8.02M | Sell |
138,198
-84,717
| -38% | -$4.14M | 0.17% | 126 |
|
|
2018
Q2 | $10.8M | Buy |
222,915
+39,717
| +22% | +$1.85M | 0.26% | 96 |
|
|
2018
Q1 | $8.52M | Buy |
183,198
+114,081
| +165% | +$4.95M | 0.18% | 125 |
|
|
2017
Q4 | $2.6M | Hold |
69,117
| – | – | 0.05% | 277 |
|
|
2017
Q3 | $2.52M | Hold |
69,117
| – | – | 0.05% | 286 |
|
|
2017
Q2 | $2.72M | Buy |
69,117
+8,748
| +14% | +$319K | 0.06% | 263 |
|
|
2017
Q1 | $1.89M | Sell |
60,369
-62,928
| -51% | -$1.97M | 0.05% | 303 |
|
|
2016
Q4 | $3.85M | Buy |
+123,297
| New | +$3.99M | 0.11% | 207 |
|
Other funds holding EW
Dai-ichi Life Insurance Company's EW Position: Q2 2026 in Review
Dai-ichi Life Insurance Company held its Edwards Lifesciences (EW) position steady in Q2 2026 at 22,329 shares worth $2.02M. The position accounts for 0.05% of the portfolio, ranked #278.
Dai-ichi Life Insurance Company first reported a position in EW in Q4 2016 and has held it in 39 quarters since. The position peaked at $13.2M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Dai-ichi Life Insurance Company held 22,329 shares of Edwards Lifesciences worth $2.02M as of Q2 2026.
- Dai-ichi Life Insurance Company left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.05% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #278 holding.
- Dai-ichi Life Insurance Company first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 39 quarters since.
- Dai-ichi Life Insurance Company's Edwards Lifesciences position peaked at $13.2M in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.